IP Library Granted Patent US 11,389,550
Granted Patent B2
US 11,389,550 · App. 16/624,946 · Granted Jul 19, 2022

Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound

Inventors: Daigo Miyajima (Saitama, JP); Toshiaki Takeuchi (Saitama, JP); Seunghyun Sim (Saitama, JP); Takuzo Aida (Saitama, JP); Ichio Aoki (Chiba, JP)
Assignees: RIKEN; NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
A61K49/10A61K49/1824C07C309/14A61K49/06A61K49/1833A61K2123/00B82Y5/00B82Y30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,389,550
App. No.
16/624,946
Granted
Jul 19, 2022
Kind
B2
Abstract

Provided is a novel nanoparticle, a contrast agent for magnetic resonance imaging containing the same, and a ligand compound used for production of the nanoparticle. The present invention relates to a nanoparticle including: a metal particle containing iron oxide; and a ligand which is bound to a metal atom on a surface of the metal particle and is represented by formula (3): where m is an integer of 1 to 4, and a broken line represents a coordinate bond with a metal atom on the surface of the metal particle.

Claims (13)

1. A nanoparticle, comprising:

a metal particle containing iron oxide; and

a ligand which is bound to a metal atom on a surface of the metal particle and is represented by formula (3):

where m is an integer of 1 to 4, and a broken line represents a coordinate bond with a metal atom on the surface of the metal particle.

2. The nanoparticle as set forth in claim 1 , wherein the ligand bound to the metal atom on the surface of the metal particle is a ligand represented by formula (1):

where a broken line represents a coordinate bond with the metal atom on the surface of the metal particle.

3. The nanoparticle as set forth in claim 1 , wherein m is 1, 2, or 4 in the formula (3).

4. The nanoparticle as set forth in claim 1 , wherein the metal particle containing the iron oxide is an iron oxide particle.

5. The nanoparticle as set forth in claim 1 , wherein the metal particle has an average particle diameter of 5 nm or less.

6. The nanoparticle as set forth in claim 5 , wherein the metal particle has an average particle diameter of 4 nm or less.

7. The nanoparticle as set forth in claim 5 , wherein the metal particle has an average particle diameter of 3 nm or less.

8. A contrast agent for magnetic resonance imaging, comprising a nanoparticle recited in claim 1 .

9. The contrast agent as set forth in claim 8 , wherein the contrast agent is a positive contrast agent.

Assignments (3)
CHANGE OF NAME Recorded May 23, 2022
From: NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY
To: NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
Reel/Frame 060163/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2020
From: AOKI, ICHIO
To: NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY
Reel/Frame 052058/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2020
From: MIYAJIMA, DAIGO; TAKEUCHI, TOSHIAKI; SIM, SEUNGHYUN; AIDA, TAKUZO
To: RIKEN
Reel/Frame 052025/0270 →
Priority Claims (1)
JP JP2017-126755 · Jun 28, 2017 · national
Continuity (1)
Related Publication 20200330617A1 · Oct 22, 2020